These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1015 related articles for article (PubMed ID: 27128301)
1. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Kim JY; Hong SM Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumors of the luminal gastrointestinal tract. Grin A; Streutker CJ Arch Pathol Lab Med; 2015 Jun; 139(6):750-6. PubMed ID: 26030244 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts. Bonds M; Rocha FG Surg Clin North Am; 2020 Jun; 100(3):635-648. PubMed ID: 32402306 [TBL] [Abstract][Full Text] [Related]
4. Recent updates on grading and classification of neuroendocrine tumors. Kim JY; Hong SM; Ro JY Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
6. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors. Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816 [TBL] [Abstract][Full Text] [Related]
7. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
8. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators. Ardill JE; O'Dorisio TM Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544 [TBL] [Abstract][Full Text] [Related]
9. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future]. Scoazec JY; Couvelard A; Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836 [TBL] [Abstract][Full Text] [Related]
10. Preface: Gastroenteropancreatic system and its tumors: Part 1. Vinik AI Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xvii-xviii. PubMed ID: 21095538 [No Abstract] [Full Text] [Related]
11. Digital image analysis of Ki67 hotspot detection and index counting in gastroenteropancreatic neuroendocrine neoplasms. Saetiew K; Angkathunyakul N; Hunnangkul S; Pongpaibul A Ann Diagn Pathol; 2024 Aug; 71():152295. PubMed ID: 38547761 [TBL] [Abstract][Full Text] [Related]
12. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract]. Klöppel G Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223 [TBL] [Abstract][Full Text] [Related]
13. Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases. Carlinfante G; Baccarini P; Berretti D; Cassetti T; Cavina M; Conigliaro R; De Pellegrin A; Di Tommaso L; Fabbri C; Fornelli A; Frasoldati A; Gardini G; Losi L; Maccio L; Manta R; Pagano N; Sassatelli R; Serra S; Camellini L Virchows Arch; 2014 Jul; 465(1):49-55. PubMed ID: 24807732 [TBL] [Abstract][Full Text] [Related]
14. Tumoral Versus Flat Intraepithelial Neoplasia of Pancreatobiliary Tract, Gallbladder, and Ampulla of Vater. Jang KT; Ahn S Arch Pathol Lab Med; 2016 May; 140(5):429-36. PubMed ID: 27128300 [TBL] [Abstract][Full Text] [Related]
15. [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies]. Bergmann F Pathologe; 2013 Nov; 34 Suppl 2():221-5. PubMed ID: 24196617 [TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414 [TBL] [Abstract][Full Text] [Related]
17. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861 [TBL] [Abstract][Full Text] [Related]
19. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas. Bellizzi AM Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624 [TBL] [Abstract][Full Text] [Related]